Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Knoxville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
PROVECTUS BIOPHARMACEUTICALS, INC. has filed 1,077 SEC EDGAR filings since 31 Mar 2000

SEC filing history

Showing 326-350 of 803 matching filings.

Per page
25
Current page
14
PRER14A File 001-36457

PRER14A

Filing date
20 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
20 Apr 2017
Reporting date
19 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 001-36457

DFAN14A

Filing date
19 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
18 Apr 2017
Reporting date
12 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-36457

PRE 14A

Filing date
17 Apr 2017
Reporting date
30 May 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-32172

SC 13D/A

Filing date
17 Apr 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
13 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
04 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
30 Mar 2017
Reporting date
30 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-32172

FORM SC 13D/A

Filing date
30 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-32172

SC 13D

Filing date
30 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
23 Mar 2017
Reporting date
19 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-32172

SC 13D/A

Filing date
21 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
20 Mar 2017
Reporting date
20 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-K File 001-36457

NT 10-K

Filing date
16 Mar 2017
Reporting date
31 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-213986

424B3

Filing date
06 Mar 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
06 Mar 2017
Reporting date
06 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
24 Feb 2017
Reporting date
24 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
23 Feb 2017
Reporting date
23 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-213986

424B3

Filing date
21 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

FORM 8-K

Filing date
21 Feb 2017
Reporting date
21 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
14 Feb 2017
Reporting date
13 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36457

8-K

Filing date
13 Feb 2017
Reporting date
10 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .